HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

Sean P. Kane, PharmD; Khyati Patel, PharmD; Michael Shuman, PharmD

1 FAN

This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowl...Show More

Best
Newest
Looking for recently uploaded episodes
080 - HIT Me With Your Best Shot: A Brief Review of Heparin-Induced Thrombocytopenia (HIT)

30:16 | Jun 26th, 2018

In this episode, we will review the diagnosis and treatment of heparin-induced thrombocytopenia (HIT).

079 - Cutting Hair and Blood Pressure: Pharmacists in the Barbershop

33:22 | Jun 5th, 2018

In this episode, we interview Kathleen Lynch, PharmD and Ciantel (Adair) Blyler, PharmD, coauthors of the New England Journal of Medicine article, published in March 2018, investigating the role of pharmacist-led interventions for blood pressure redu...Show More

078 - Transitioning from School to Practice - Advice for New Practitioners

30:32 | May 15th, 2018

In this episode, we interview Janeen Winnike, Dean of the Office of Students Affairs at the RFUMS College of Pharmacy, regarding transitions from a student life to a practitioner life. With her previous role as an HR official within a large community...Show More

077 - PE: Not Just a Class in Junior High -- Top 5 Clinical Pearls about Pulmonary Embolism

31:43 | Apr 24th, 2018

In this episode, we discuss five clinical pearls about pulmonary embolism ranging from PE diagnosis, classification, and treatment. We specifically examine when and how alteplase is given for PE and its use with concurrent anticoagulation.

076 - The New Move: Treating Tardive Dyskinesia

36:06 | Apr 3rd, 2018

In this episode, we discuss two new agents (valbenazine and deutetrabenazine) -- the first of their kind to receive FDA approval to manage tardive dyskinesia most commonly associated with antipsychotic use.

075 - Taking a break: perioperative management of anticoagulants and antiplatelets, Part II

20:26 | Mar 13th, 2018

In the previous episodes, we discussed how we should evaluate a patient’s bleeding and clotting risks as well as looked at recommendation for management for various anticoagulants. In this episode, we will continue the discussion to management of ant...Show More

074 - Taking a break: perioperative management of anticoagulants and antiplatelets, Part I

31:07 | Feb 20th, 2018

In this episode, we will discuss some important factors to consider in management of various anticoagulants. We will also provide agent specific pharmacodynamic and pharmacokinetic based recommendations.

073 - Don’t go with the flow: how antibiotics cause diarrhea and what you can do about it

32:55 | Jan 30th, 2018

In this episode, we discuss the efficacy and safety of probiotics for the prevention of antibiotic-associated diarrhea (AAD) and Clostridium difficile-associated diarrhea (CDAD).

072 - Drop It Like It’s Hot: Prazosin and the 2017 VA/DoD PTSD Guidelines

36:29 | Jan 9th, 2018

In this episode, we will review the surprising results of the VA/DoD's 2017 Clinical Practice Guidelines on Management of PTSD, particularly as it relates to the use of one particular agent, prazosin.

071 - Holy Hypertension Guidelines - Holiday Edition!

35:14 | Dec 19th, 2017

In this episode, we review the important changes in 2017 ACC/AHA guidelines for hypertension management in adults.

070 - Does rosuvastatin REALLY cause 42 adverse drug reactions? Identifying true ADRs to improve your patient counseling

26:01 | Nov 28th, 2017

In this episode, we discuss the difficulty in identifying adverse drug reactions (ADR) that ACTUALLY occur from a drug therapy, how tertiary drug references (such as Micromedex or LexiComp) may be misleading, and what tips and tricks you can use to r...Show More

069 - The pharmacist must see you now - A new rule requiring pharmacist counseling in Illinois

37:21 | Nov 7th, 2017

In this episode, we interview Dylan Moe, PharmD, our very own alumnus, regarding the new Illinois rule requiring patient counseling for all new prescriptions and inquire how the new rule has impacted his pharmacy, work environment, and his opinions o...Show More

068 - Hooked on a feeling: how to discuss benzodiazepine tapers with your patients

35:58 | Oct 17th, 2017

In this episode, we will discuss the current state of benzodiazepine use, expected trends in prescribing, and risks associated with use. Lastly, we will discuss techniques for ensuring that a benzodiazepine taper is performed in a safe manner with lo...Show More

067 - Diabetes: does it cost a “heart” and a leg?

28:21 | Sep 26th, 2017

In this episode, we discuss new evidence for cardiovascular outcomes in diabetics based on the LEADER trial (liraglutide) and CANVAS trials (canagliflozin). We also discuss the new FDA warning for canagliflozin regarding amputation risk.

066 - What’s new in the diabetes world? Tapas style!

41:10 | Sep 5th, 2017

In this episode, we discuss updates in diabetes management that includes nuances from the ADA’s Standards of Care 2017. We also review some newer pharmacologic agents, a fixed dose GLP-1 agonist and basal insulin combinations.

065 - Advanced hypertension ninja skills with some of the oldest BP meds

33:23 | Aug 15th, 2017

In this episode, we discuss three "older" antihypertensives that are not preferred first-line therapies: clonidine, methyldopa, and minoxidil.  We outline why these agents are not first-line therapies and review their pharmacology and adverse effect ...Show More

064 - Should I stay or should ergot?

27:16 | Jul 25th, 2017

In this episode, we discuss the history of ergot products for treatment of migraines. We compare their safety and efficacy to newer agents such as the triptans and assess their resultant place in therapy.

063 - More is not always better - Story of Serotonin Syndrome

37:09 | Jul 4th, 2017

In this episode, we discuss several aspects of serotonin syndrome including the typical clinical presentation, its etiology and common drug-induced combinations, and how to appropriately manage the syndrome.

062 - Devices not drugs: stroke risk reduction in atrial fibrillation

21:16 | Jun 13th, 2017

In this episode, we discuss the pathophysiology of embolic stroke in patients with atrial fibrillation and review the use of left atrial occlusion devices, such as the WATCHMAN device, to reduce the risk of stroke in patients with atrial fibrillation...Show More

061 - Correcting the course: careful opioid prescribing

33:27 | May 23rd, 2017

In this episode, we review the 12 recommendations from the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain.  These recommendations are intended to help curb the opioid epidemic and provide guidance to healthcare providers regarding safer ...Show More

060 - How to get your voice heard? - Pearls of Professional Advocacy

27:03 | May 2nd, 2017

In this episode, we discuss the concept of professional advocacy, with a particular focus on how to advocate for the profession of pharmacy and what tools and organizations are available to assist in being an advocate.

059 - The five oncology drugs every pharmacist should know about

37:51 | Apr 11th, 2017

In this episode, we discuss with Dr. Megan Hartranft the five oncology drugs that every pharmacist should know about, which is a great review for P4 students who are currently preparing for the NAPLEX.  We cover cyclophosphamide, cisplatin, methotrex...Show More

058 - Third time’s a charm -- redefining sepsis (again) using Sepsis-3

25:27 | Mar 21st, 2017

In this episode, we discuss the newest definition of sepsis and septic shock according to the Sepsis-3 criteria and the 2016 Surviving Sepsis guidelines.  We also review the scoring systems of “qSOFA” and “SOFA” and use a patient case to help demonst...Show More

057 - Kicking acid, taking names ... the story of PPI use and abuse

28:52 | Feb 28th, 2017

In this episode, we discuss the overuse of proton pump inhibitor (PPI) therapy and several concerns regarding chronic use of this medication class, including hypomagnesemia, fracture risk, low seurm B12 levels, anemias, and increased risk of certain ...Show More

056 - Entering the era of biosimilars!

31:38 | Feb 7th, 2017

In this episode, we discuss the new FDA categorizations of biosimilars, the legal implications of biologic/biosimilar prescriptions, and the new "follow-on" approval pathway of Basaglar, a new insulin glargine U-100 product.

055 - How low can you go? Blood pressure limbo with SPRINT

25:51 | Jan 17th, 2017

In this episode, we discuss the SPRINT trial (intensive vs. standard blood pressure control) using a case vignette of Mr. Wilson, a 55 year old patient presenting to a clinic with a blood pressure of 139/89 mmHg.

054 - So you think you can precept? Advice from the front lines

23:38 | Dec 27th, 2016

In this episode, we discuss precepting tips and clinical pearls with Dr. Brad Cannon.

053 - Drug Mixology and Dangerous Consequences, Part II

23:02 | Dec 6th, 2016

In this episode, we discuss more of the most important drug interactions, including grapefruit juice with statins and calcium channel blockers, QT prolonging medications, levothyroxine with cations and PPIs, and PDE-5 inhibitors with nitrates.

052 - Drug Mixology and Dangerous Consequences, Part I

28:34 | Nov 15th, 2016

In this episode, we discuss some of the most important drug interactions, including serotonin syndrome, St. John's wort, statins and CYP inhibitors, and antihypertensive medications with NSAIDs.

051 - Pharmacists to the Rescue!

32:26 | Oct 25th, 2016

In this episode, we discuss two new naloxone devices (intramuscular Evzio and intranasal Narcan) and review new state laws that are expanding the role of pharmacists in dispensing these opioid reversal products.

050 - Three shocking recommendations from CHEST 2016 that will blow your mind

26:58 | Oct 4th, 2016

In this episode, we discuss three shocking recommendations from the CHEST 2016 VTE guideline update.  We focus on (1) the debate between NOAC, DOAC, or TSOAC nomenclature, (2) the controversial recommendation of preferring NOACs over warfarin in VTE ...Show More

049 - The RFUMS Interprofessional Community Clinic

40:25 | Sep 13th, 2016

In this episode, we discuss RFUMS's Interprofessional Community Clinic (ICC), a student-run clinic providing health services to underserved populations.  The students in this episode discuss how the ICC evolved and highlight pearls and challenges in ...Show More

048 - Self-Care of Nasal Congestion and Allergies

41:00 | Aug 23rd, 2016

In this episode, we discuss the self-care of nasal congestion and allergies, including systemic/topical decongestants, nasal corticosteroids, antihistamines, cromolyn, and alternative medicine therapies.

047 - Self-Care of Cough and Cold

35:56 | Aug 2nd, 2016

In this episode, we discuss self-care of cough and cold, including using PQRSTA or SCHOLAR-MAC to prompt relevant questions for patients, codeine, dextromethorphan, diphenhydramine, camphor, menthol, and guaifenesin.

046 - Self-Care of Constipation

17:27 | Jul 12th, 2016

In this episode, we discuss self-care of constipation including bulk-forming laxatives, hyperosmotic laxatives, emollient laxatives, lubricant laxatives, saline laxatives, and stimulant laxatives.

045 - Self-care of Heartburn and Dyspepsia

20:32 | Jun 21st, 2016

In this episode, we discuss self-care of heartburn and dyspepsia, including antacids, bismuth subsalicylate, H2 blockers, and PPIs.

044 - The Science of Sugars and Sweeteners with Dr. Eric Walters

33:57 | May 31st, 2016

In this episode, we discuss the science of carbohydrate-based sugars, sugar alcohols, artificial sweeteners, and natural sweeteners with Dr. Eric Walters, author of the book "The Sweetener Book" and Professor at Rosalind Franklin University.

043 - Review of Diabetic Ketoacidosis (DKA)

27:30 | May 10th, 2016

In this episode, we review the clinical presentation and treatment of diabetic ketoacidosis (DKA).

042 - BRIDGE Trial

21:48 | Apr 19th, 2016

In this episode, we discuss the BRIDGE trial, which investigated whether patients with atrial fibrillation on warfarin need a parenteral anticoagulant "bridge" in preparation and after an elective surgical procedure.

041 - 2015 Dietary Guidelines for Americans

33:42 | Mar 29th, 2016

In this episode, we discuss the 2015-2020 Dietary Guidelines for Americans published by the U.S. Department of Health and Human Services and U.S. Department of Agriculture.

040 - Homeopathic Medicine

36:46 | Mar 8th, 2016

In this episode, we discuss the many facets of homeopathic medications, including legal status in the United States, safety and efficacy data, and the ethics of homeopathy from the point of view of practicing pharmacists.

039 - Diclegis (doxylamine-pyridoxine) and nausea/vomiting of pregnancy

27:33 | Feb 16th, 2016

In this episode, we discuss nausea and vomiting of pregnancy (NVP) with a particular focus on Diclegis (doxylamine/pyridoxine).

038 - Suvarexant (Belsomra) - a new drug class for insomnia

39:53 | Jan 26th, 2016

In this episode, we discuss suvarexant (Belsomra), the first dual orexin receptor antagonist approved in the United States for the treatment of insomnia.

037 - Understanding Creatinine Clearance

29:11 | Jan 5th, 2016

In this episode, we have an in-depth review of how to measure glomerular filtration rate (GFR), including variants of the Cockcroft-Gault equation and newer, more accurate methods that may eventually be used to renally adjust certain medications.

036 - Two new agents for schizophrenia

33:06 | Dec 15th, 2015

In this episode, we discuss two agents newly approved for schizophrenia -- Rexulti (brexpiprazole) and cariprazine (Vraylar).

035 - Empagliflozin and dulaglutide

34:23 | Nov 24th, 2015

In this episode, we discuss two new anti-diabetic medications: empagliflozin (Jardiance) and the EMPA-REG OUTCOME trial as well as dulaglutide (Trulicity), a new GLP1 agonist.

034 - New Injectable Insulins

31:06 | Nov 3rd, 2015

In this podcast, we discuss three new injectable insulin formations: Toujeo (insulin glargine U-300), Humalog U-200 (insulin lispro), and Tresiba (insulin degludec).

033 - PCSK9 Inhibitors

32:01 | Oct 13th, 2015

In this episode, we discuss PCSK9 inhibitors, a new drug class for LDL lowering, with a particular focus on alirocumab (Praluent).

032 - ARNIs and Entresto

33:07 | Sep 22nd, 2015

In this episode, we discuss the new drug class, ARNI, recently approved for heart failure with a focus on sacubatril/valsartan (Entresto) and the PARADIGM-HF trial.

031 - Therapeutic Drug Monitoring III

26:53 | Sep 1st, 2015

In this episode, we discuss the therapeutic drug monitoring and dose adjustments for tacrolimus (Prograf) and lithium.

030 - Therapeutic Drug Monitoring II

42:04 | Aug 11th, 2015

In this episode, we discuss the therapeutic drug monitoring and dose adjustments for valproic acid (Depakote/Depakene/Depakon) and digoxin (Lanoxin).

029 - Therapeutic Drug Monitoring I

39:34 | Jul 21st, 2015

In this episode, we discuss the therapeutic drug monitoring and dose adjustments for warfarin (Coumadin) and phenytoin (Dilantin).

028 - Malaria Prophylaxis

28:54 | Jun 30th, 2015

In this episode, we discuss malaria prophylaxis with atovaquone/proguanil, chloroquine, hydroxychloroquine, doxycycline, mefloquine, and primaquine.

027 - Six Pivotal Drug Classes, Part 2

34:58 | Jun 9th, 2015

In this episode, we discuss six pivotal drug classes that have been FDA approved within the past 20 years. This is part 2 of a 2 part episode.

026 - Six Pivotal Drug Classes, Part 1

31:12 | May 19th, 2015

In this episode, we discuss six pivotal drug classes that have been FDA approved within the past 20 years.  This is part 1 of a 2 part episode.

025 - An Interview with Dr. Brad Cannon, PharmD

33:53 | Apr 28th, 2015

In this episode, we interview Brad Cannon, PharmD regarding his career path in pharmacy and his viewpoints on the pharmacy profession.

024 - Case vignettes of depression, hypertension, and diabetes mellitus

37:41 | Apr 7th, 2015

In this episode, we discuss the optimal drug therapy for three different case vignettes -- depression, hypertension, and diabetes mellitus.

023 - Hepatitis C

38:14 | Mar 16th, 2015

In this episode, we review historical and new treatment options for hepatitis C, including: peginterferon, rivabirin, boceprevir, telaprevir, sofosbuvir (Sovaldi), simeprevir (Olysio), ombitasvir/paritaprevir/ritonavir/dasabuvir (Viekira Pak), and le...Show More

022 - Sedation Minimization

28:02 | Mar 3rd, 2015

In this episode, we discuss the pharmacology of oversedation, the importance of sedation minimization strategies in mechanically ventilated patients, and overview the sedatives and analgesics commonly used in this patient population.

021 - Opioid-Induced Respiratory Depression, Reversal, and Non-Narcotic Alternatives

32:24 | Feb 10th, 2015

In this episode, we discuss risk factors for opioid-related adverse events, naloxone (Narcan, Evzio), and a number of non-narcotic agents for neuropathic pain.

020 - SMART

22:11 | Jan 20th, 2015

In this episode, we summarize and discuss the clinical implications of the SMART trial (Salmeterol Multicenter Asthma Research Trial; Nelson et al, 2006).

019 - Immunizations

21:25 | Dec 16th, 2014

In this episode, we discuss two controversial topics in the world of immunizations with Dr. Angelo -- the "high-dose" influenza vaccine and the expanded use of PCV13 (Prevnar-13).

018 - HIV

34:33 | Dec 2nd, 2014

In this episode, we review HIV therapy with Dr. Cottreau with a particular focus on Truvada, Atripla, Complera, Stribild, and Triumeq.

017 - Overactive bladder

22:52 | Nov 18th, 2014

In this episode, we discuss the management of overactive bladder, including: oxybutynin (Ditropan, Oxytrol), tolterodine (Detrol), trospium (Sanctura), solifenacin (VESIcare), darifenacin (Enablex), fesoterodine (Toviaz), mirabegron (Myrbetriq), and ...Show More

016 - New diabetes medications

35:57 | Nov 4th, 2014

In this episode, we discuss newly approved agents for diabetes mellitus: Afrezza (inhaled human insulin), SGLT2 inhibitors (Invokana, Farxiga, Jardiance), and long-acting GLP-1 agonists (Bydureon, Tanzeum).

015 - Cancer Screenings

1:01:47 | Oct 21st, 2014

In this episode, we review a wide variety of cancer screening guidelines with a particular focus on the two most controversial screening areas: breast cancer screening with mammography and prostate cancer screening with PSA levels.

014 - Midyear Table Talk

31:08 | Oct 7th, 2014

In this episode, we have a roundtable discussion regarding ASHP Midyear and the process of pursuing a pharmacy residency program.

013 - Obesity Guidelines and Weight Loss Pharmacotherapy

37:17 | Sep 23rd, 2014

In this episode, we discuss the new 2013 ACC/AHA obesity guidelines with a particular focus on three medications for obesity: lorcaserin (Belviq), phentermine/topiramate (Qsymia), and orlistat (Xenical, Alli).

012 - Osteoporosis Guidelines and Two Newer Agents

32:50 | Sep 9th, 2014

In this episode, we review the National Osteoporosis Foundation's osteoporosis guidelines with a particular focus on two newer agents, denosumab (Prolia) and teriparatide (Forteo).

011 - Bordetella pertussis

32:32 | Aug 26th, 2014

In this episode, we discuss Bordetella pertussis (whooping cough) with Dr. Michael Fennewald.

010 - Pet Peeves

37:25 | Aug 12th, 2014

In this episode, we discuss our clinical "pet peeves" covering allergy histories, creatinine clearance, surrogate endpoints, "me too" enantiomer drugs, and dose-dependent pharmacology of psychiatric medications.

009 - Combining ACE-I, ARB, and DRIs

21:49 | Jul 29th, 2014

In this episode, we discuss the pharmacology of the renin-angiotensin-aldosterone system and review the evidence for combining ACE-Is, ARBs, and/or DRIs.

008 - HCAP, HAP, and VAP

28:50 | Jul 15th, 2014

In this episode, we discuss the 2005 ATS/IDSA Healthcare-Associated, Hospital-Acquired, and Ventilator-Associated Pneumonia Guidelines (HCAP, HAP, VAP).

007 - Community-Acquired Pneumonia Guidelines

24:34 | Jul 1st, 2014

In this episode, we discuss the 2007 ATS/IDSA Community-Acquired Pneumonia (CAP) guidelines.

006 - Updates to GOLD Guidelines and COPD

27:18 | Jun 17th, 2014

In this episode, we discuss updates to the GOLD guidelines for COPD and review the newer agents for COPD including roflumilast (Daliresp), indacaterol (Arcapta Neohaler), aclidinium (Tudorza Pressair), umeclidinium/vilanterol (Anoro Ellipta), and flu...Show More

005 - Smoking Cessation

21:31 | Jun 3rd, 2014

In this episode, we discuss smoking cessation, including nicotine replacement therapy, bupropion (Zyban), and varenicline (Chantix).

004 - P2Y12 Inhibitors, DAPT, and TOAT

30:31 | May 20th, 2014

In this episode, we discuss the P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) and the role of dual antiplatelet therapy (DAPT) and triple oral antithrombotic therapy (TOAT).

003 - Novel Oral Anticoagulants (NOACs)

26:00 | May 6th, 2014

In this episode, we discuss the new drug class of Novel Oral Anticoagulants (NOACs), which include dabigatran (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis).

002 - Antihypertension Guidelines (JNC 8 and more)

26:10 | Apr 22nd, 2014

In this episode, we discuss the new JNC 8 guidelines and how these guidelines differ from other hypertension guidelines released in 2013-2014.

001 - 2013 ACC/AHA Lipid Guidelines

17:32 | Apr 8th, 2014

In this episode, we discuss the new, rebranded podcat (HelixTalk) and review the new ACC/AHA 2013 lipid guidelines.

Top 200 Drugs - Women's Health

28:18 | Mar 5th, 2014

In this session of the RFUMS Top 200 Drugs Podcast, we discuss women’s health: conjugated estrogens, ethinyl estradiol, norethindrone, norgestrel, etonogestrel, medroxyprogesterone, raloxifene, tamoxifen, miconazole, Midol, phenazopyridine.

Top 200 Drugs - GI Medications

24:40 | Mar 5th, 2014

In this session of the RFUMS Top 200 Drugs Podcast, we discuss GI medications: methotrexate, allopurinol, mesalamine, esomeprazole, pantoprazole, rabeprazole, sucralfate, dicyclomine, simethicone, pyrantel, and lactase enzyme.

Top 200 Drugs - Antiemetics, Antitussives, and Antihistamines

28:48 | Mar 5th, 2014

In this session of the RFUMS Top 200 Drugs Podcast, we discuss antiemetics, antitussives, and antihistamines: hydroxyzine, meclizine, metoclopramide, prochlorperazine, ondansetron, chlorpheniramine/hydrocodone, promethazine/codeine, desloratadine, di...Show More

Top 200 Drugs - Men's Health

26:03 | Mar 5th, 2014

In this session of the RFUMS Top 200 Drugs Podcast, we discuss men’s health: terazosin, doxazosin, tamsulosin, finasteride, sildenafil, vardenafil, tadalafil, oxybutynin, tolterodine, minoxidil, and nonoxynol-9.

Top 200 Drugs - Muscle Relaxants, Stimulants, and Anticonvulsants

27:26 | Mar 5th, 2014

In this session of the RFUMS Top 200 Drugs Podcast, we discuss muscle relaxants, stimulants, and anticonvulsants: baclofen, carisoprodol, metaxalone, cyclobenzaprine, methylphenidate, Adderall, lisdexamfetamine, phenytoin, divalproex, DEET, tolnaftat...Show More

Top 200 Drugs - Antidepressants and Antipsychotics

18:53 | Mar 5th, 2014

In this session of the RFUMS Top 200 Drugs Podcast, we discuss antidepressants and antipsychotics: bupropion, venlafaxine, aripiprazole, quetiapine, risperidone, olanzapine, carbidopa/levodopa, pramoxine, Neosporin, and povidone/iodine.

Top 200 Drugs - Antidepressants

19:27 | Mar 5th, 2014

In this session of the RFUMS Top 200 Drugs Podcast, we discuss antidepressants: citalopram, escitalopram, sertraline, fluoxetine, paroxetine, duloxetine, amitriptyline, trazodone, fexofenadine, oxymetazoline, and pheniramine.

Top 200 Drugs - Sleep Agents and Neuropathic Pain

22:12 | Mar 5th, 2014

In this session of the RFUMS Top 200 Drugs Podcast, we discuss sleep agents and neuropathic pain: alprazolam, clonazepam, diazepam, lorazepam, zolpidem, zaleplon, gabapentin, pregabalin, and lidocaine.

Top 200 Drugs - Osteoporosis

19:49 | Mar 5th, 2014

In this session of the RFUMS Top 200 Drugs Podcast, we discuss agents for osteoporosis: calcitonin, alendronate, risedronate, ibandronate, potassium chloride, and calcium citrate.

Top 200 Drugs - COPD and Asthma

16:43 | Mar 5th, 2014

In this session of the RFUMS Top 200 Drugs Podcast, we discuss agents for COPD and asthma: albuterol, levalbuterol,  ipratropium, tiotropium, albuterol/ipratropium, fluticasone, mometasone, fluticasone/salmeterol, and formoterol/budesonide.

Top 200 Drugs - Opioid Analgesics

18:21 | Mar 5th, 2014

In this session of the RFUMS Top 200 Drugs Podcast, we discuss opioid analgesics: morphine sulfate, codeine/APAP, oxycodone, oxycodone/APAP, hydrocodone/APAP, hydrocodone/ibuprofen, fentanyl, and bisacodyl.

Top 200 Drugs - Pain Relievers

13:37 | Mar 5th, 2014

In this session of the RFUMS Top 200 Drugs Podcast, we discuss pain relivers: meloxicam, celecobix, ketorolac, tramadol, tramadol/APAP, capsaicin, and methyl salicylate.

Top 200 Drugs - Antifungals, Antivirals

16:53 | Mar 5th, 2014

In this session of the RFUMS Top 200 Drugs Podcast, we discuss antifungals and antivirals: fluconazole, itraconazole, ketoconazole, oseltamivir, acyclovir, valacyclovir, docosanol, terbinafine, and clotrimazole or miconazole.

Top 200 Drugs - Antibiotics

12:33 | Mar 5th, 2014

In this session of the RFUMS Top 200 Drugs Podcast, we discuss antibiotics: metronidazole, clindamycin, doxycycline, nitrofurantoin, sulfamethoxazole/trimethoprim, mupirocin, zinc oxide, and polyethylene glycol 400.